Epithelial ovarian carcinoma of low malignant potential

Daraı̈, Émile; Teboul, Joelle; Walker, Francine; Bénifla, J.-L.; Meneux, E.; Guglielmina, Jean Noel; Pennehouat, G.; Renolleau, C; Sebban, E; Madelenat, P.

doi:10.1016/0301-2115(96)02418-9

Cited by 24 publications

(22 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been argued that serous BOT are associated with elevated CA-125 compared with mucinous BOT [15,17,21], however, the evidence is conflicting and other studies have not confirmed these observations [12,22,24]. CA 19.9 CA 19.9 levels are elevated in up to 49% of women with BOT [14][15][16]18] (Table 1). One study reported a higher proportion of patients having serous tumors being testing positive for CA 19.9 as compared with patients having mucinous tumors (51.5 vs. 44.7%) [15].…”

Section: Ca-125mentioning

confidence: 86%

“…Published studies reported elevated serum CA-125 levels in 24-61% patients with BOT [3,[12][13][14][15][16][17][18][19][20][21] (Table 1). The wide range may be explained by the varying portion of advanced-stage BOT and histological types in the published series.…”

Section: Ca-125mentioning

confidence: 91%

“…Preoperative levels of CEA in patients with BOT (Table 1) have been reported as elevated in up to 17% of patients [14][15][16]. Both the proportions of patients testing positive, and overall serum levels of CEA are higher in mucinous tumor than in serous tumor [3,15].…”

Section: Carcinoembryonic Antigen (Cea)mentioning

confidence: 93%

See 2 more Smart Citations

The preoperative diagnosis of borderline ovarian tumors: a review of current literature

Morotti

Menada

Gillott

et al. 2011

Arch Gynecol Obstet

View full text Add to dashboard Cite

After completion of this article, the reader should be aware of the symptoms of BOTs, the potential role and pitfalls of tumor marker measurement. In addition, the reader will understand the appearance of BOTs at imaging techniques; the reader will be able to compare and combine ultrasonography, MRI and positron emission tomography in diagnosing BOTs. In clinical practice, the reader should be better able to assess whether an ovarian mass is a benign tumor, a BOT or an invasive cancer.

show abstract

Section: Ca-125mentioning

confidence: 86%

Section: Ca-125mentioning

confidence: 91%

See 1 more Smart Citation

The preoperative diagnosis of borderline ovarian tumors: a review of current literature

Morotti

Menada

Gillott

et al. 2011

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

“…This could be due to the relatively low incidence of abnormal serum tumor markers in women with BOT, both preoperatively and during recurrences (8,13,22,25,32).…”

Section: Relevance Of Serum Tumor Marker Determination For Recurrencementioning

confidence: 99%

“…Serum tumor markers have been evaluated in only small series of women with BOT, and their contribution to treatment and follow-up is unclear (22)(23)(24).…”

Section: Accepted As a Distinct Histological Entity By The Internatiomentioning

confidence: 99%

Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: Multivariate analysis of a French multicentre study

Poncelet

Fauvet

Yazbeck

et al. 2010

European Journal of Surgical Oncology

View full text Add to dashboard Cite

To cite this version:C. Poncelet, R. Fauvet, C. Yazbeck, C. Coutant, E. Darai. Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: Multivariate analysis of a french multicentre study. EJSO -European Journal of Surgical Oncology, WB Saunders, 2010, 36 (11) This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 1 IMPACT OF SERUM TUMOR MARKER DETERMINATION ON THE MANAGEMENT OF WOMEN WITH BORDERLINE OVARIAN TUMORS: MULTIVARIATE ANALYSIS OF A FRENCH MULTICENTRE STUDY.C PONCELET 1-2 , R FAUVET 1 , C YAZBECK 3 , C COUTANT 1 , and E DARAI 1 *. Condensation:Preoperative evaluation of serum tumor markers impacts on the management of borderline ovarian tumors.3 Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.C PONCELET, R FAUVET, C YAZBECK, C COUTANT, and E DARAI. ABSTRACT:Objective: To evaluate the contribution of preoperative serum tumor markers to manage borderline ovarian tumors (BOT).Study Design: Retrospective multicentre study including 317 BOT. Serum tumor marker levels of CA125, CA19-9, CEA, and CA15-3 were determined by radio-immunoassay. Conclusion: Serum tumor marker assays modified both preoperative assessment and surgical management of BOT. Results

show abstract

Current management of epithelial ovarian carcinoma: A review

Marsden

Friedlander

Hacker

2000

Semin. Surg. Oncol.

View full text Add to dashboard Cite

Epithelial carcinoma of the ovary is the most lethal of gynaecological malignancies and it affects about one in 70 women in developed countries. Over 75% of women with the disease have tumour spread beyond the pelvis at the time of diagnosis, and their treatment requires the appropriate use of surgery and chemotherapy. The strategies used in the treatment of ovarian cancer are constantly evolving. An overview of current treatment regimens and their evolution is provided, with particular emphasis on the interdependence of surgery and chemotherapy in the optimal management of the disease. Semin. Surg. Oncol. 19:11–19, 2000. © 2000 Wiley‐Liss, Inc.

show abstract

Epithelial ovarian carcinoma of low malignant potential

Cited by 24 publications

References 3 publications

The preoperative diagnosis of borderline ovarian tumors: a review of current literature

The preoperative diagnosis of borderline ovarian tumors: a review of current literature

Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: Multivariate analysis of a French multicentre study

Current management of epithelial ovarian carcinoma: A review

Contact Info

Product

Resources

About